TipHub

₹6.38

■ +0 +0.00%

29 Jul 2026

BSE Listed

GSM · GSM 0
What does GSM · GSM 0 mean?
BSE · Graded Surveillance Measure (GSM 0)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).Exchange notice · 2026-06-25

Decipher Labs Limited (524752)

Volume: 0Avg Vol 1W: 3,390Avg Vol 1M: 4,69552W Range:₹5₹11.66
BSE www.decipherlabs.in AI Report
Key Ratios
Checked just now
Market Cap₹6 Cr
Current Price₹6.38
Previous Close₹6.38
High / Low (52w)₹11.66 / ₹5
Volume0
Avg Vol (1W)3,390
Avg Vol (1M)4,695
Stock P/E—
Book Value₹20.47
Dividend Yield0%
ROE-14.93%
ROA-17.71%
Revenue (TTM)—
Revenue Growth—
Profit Margin-30.7%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B0.31
Debt / Equity0.01
50 DMA₹6.75
200 DMA₹8.01
Day change+0.00%
SurveillanceGSM · GSM 0
Price Chart
₹6.38▼ 42.63% · 1Y
₹13₹597K
2025-07-29
2026-07-29

20-day avg volume: 5K shares

Pros
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Revenue fell 46% YoY.
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹7 Cr₹6 Cr₹6 Cr₹4 Cr₹3 Cr₹4 Cr₹3 Cr₹4 Cr
EBITDA₹1 Cr₹-1 Cr₹-1 Cr₹-6 Cr₹-3 Cr₹0 Cr₹-1 Cr₹0 Cr
Net Profit₹1 Cr₹-1 Cr₹-1 Cr₹-4 Cr₹-3 Cr₹0 Cr₹-1 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹24 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹-6 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹-5 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS——-5.03—————
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹3 Cr₹6 Cr₹35 Cr₹39 Cr₹42 Cr₹28 Cr₹34 Cr₹26 Cr
Total Liabilities₹1 Cr₹4 Cr₹23 Cr₹25 Cr₹18 Cr₹5 Cr₹12 Cr₹3 Cr
Equity₹2 Cr₹3 Cr₹13 Cr₹14 Cr₹24 Cr₹23 Cr₹22 Cr₹23 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹0 Cr₹-15 Cr₹2 Cr₹8 Cr₹-2 Cr₹5 Cr₹-10 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-4 Cr₹-2 Cr₹3 Cr
Financing₹0 Cr₹0 Cr₹16 Cr₹4 Cr₹1 Cr₹-2 Cr₹-1 Cr₹0 Cr
Free Cash Flow₹0 Cr₹0 Cr₹-15 Cr₹2 Cr₹8 Cr₹-2 Cr₹5 Cr₹-10 Cr
Shareholding
Promoter 16.43% Institutions 0% Public 83.57%
Efficiency & Working Capital
ROCE-17.4%
Interest Coverage0
Dividend Payout—
Debtor Days68 d
Inventory Days0 d
Payable Days19 d
Cash Conversion Cycle49 d
Working Capital Days68 d
Shareholding Details

As of 2026-06-30

Promoter16.4%
FII0%
DII0%
Institutions0%
Public83.6%
Promoter Pledge0%
No. of Shareholders29,368
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters16.4%16.4%16.4%16.4%16.4%16.4%16.4%16.4%16.4%16.4%16.4%16.4%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public83.6%83.6%83.6%83.6%83.6%83.6%83.6%83.6%83.6%83.6%83.6%83.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders35,72834,51133,37132,83331,83831,48231,18230,51230,17429,82529,59629,368
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Ajjarapu JanakiramShareholding of Promoter and Promoter Group16.4%16,59,075
Seshu Srinivas AkulaPublic Shareholding3.8%3,84,273
Sushant Mohan LalPublic Shareholding2.1%2,16,315
Suriadoss ElumalaiPublic Shareholding1.4%1,43,655
Shri Krishna Maheshwari(huf)Public Shareholding1.4%1,38,764
Cyril SebastianPublic Shareholding1.2%1,20,729
Suman ChepuriPublic Shareholding1.1%1,05,662
Board of Directors
NameDesignationYear
Sushant Mohan LalNon-Exec & Non-Independent Dir2025
G Venkateswara RaoIndependent Non Exe. Director2025
Lakshmi Vijaya NimmalaIndependent Non Exe. Director2025
Janakiram AjjarapuNon Executive Director2025
Gayathri RaghuramIndependent Non Exe. Director2025
Preeti SinghCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharma₹1 Cr80.4%
Consultancy₹0 Cr19.6%
Segments — Geography
RegionRevenueShare
India₹1 Cr80.4%
Outside India₹0 Cr19.6%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10101010
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000011
2025000011
2025000000
Substantial Acquisitions (SAST)

3 disclosure(s)

Market29/12/2021 · 2,99,000
Market29/12/2021 - 30/12/2021 · 10,00,000
Market15/12/2021 · 6,50,000
Company Information
Incorporated1986
AuditorRamanatham & Rao
Investor Email[email protected]; [email protected]
🌐 www.decipherlabs.in ↗

📍 4th Flr Plot-94 Sagar Society, Banjara Hills Road No 2, Hyderabad, Telangana, 500034

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Span Divergent LimitedJenburkt Pharmaceuticals Ltd.HikalCaplin Point LaboratoriesFischer Medical VenturesLink Pharma Chem Ltd.Emmessar Biotech & Nutrition Ltd.NGL Fine ChemEverest Organics Ltd.Phyto Chem (India) Ltd.Dynamic Industries Ltd.BDH Industries Ltd.All “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search